June 7, 2022
In-person presentation on Monday, June 13th at 1:45 PM PT CARLSBAD, Calif. , June 07, 2022 (GLOBE NEWSWIRE) -- Palisade Bio  (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that Tom Hallam ,
May 6, 2022
CARLSBAD, Calif. , May 06, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it has entered into definitive
Displaying 1 - 10 of 18
Print Page
RSS Feeds
Email Alerts
Contact IR
Search